Covance Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (36)

Latest Posts

About This Stock More About This Stock
Market Briefing For Jan. 13, 2020
Article By: Gene Inger
Sunday, January 12, 2020 11:17 PM EDT
There's no catalyst to warrant committing new funds as yet; although I expected 'recent' extensions, and leaned very clearly towards a China Deal coming; with initially higher S&P records.
In this article: AMD, AMRN, AAPL, DAL, BA, SPX, NYA, CVD, GILD
Read
ROTH Capital's Debjit Chattopadhyay: Marriage Of Diagnostics To New Therapies Breeds Biotech Winners
Article By: The Life Sciences Report
Wednesday, September 24, 2014 4:53 PM EDT
A medical researcher turned biotech analyst highlights several companies with unique diagnostic and therapeutic technologies.
In this article: BAX, CVD, DGX, NGNM, RHHBY, INCY, CTIC, RNA, SRPT
Read
Large Cap Best And Worst Report
Article By: E.B. Capital Markets
Wednesday, April 2, 2014 4:38 AM EDT
The average large cap score is 61.28, below the four week moving average of 64.18. The average large cap is trading -9.6% below its 52 week high, 4.52% above its 200 dma, has 3.94 days to cover held short, and is expected to generate EPS growth of 14% next year.
In this article: AMX, APH, AXP, C, CLB, CSX, CVD, EIX, ESS, EW, GGB, JNJ, KGC, MAT, NMR, RAX, TDG, WEC, BBBY, MCHP, QGEN, ZTS
Read
Large Cap Best And Worst
Article By: E.B. Capital Markets
Wednesday, February 26, 2014 2:34 PM EDT
The highest scoring names in large cap from 1 year ago (2/26/2013) returned 263 bps more than the S&P 500. The best performers are GILD up 95%, PCLN up 94%, MYL up 83%, YHOO up 80%, TMO up 69%, and XEC up 69%.
In this article: AGN, AMP, AON, APH, AZO, BCR, BDX, BWA, C, CAH, CF, CHL, CHU, CLR, CVD, DGX, DIS, ECA, FRT, GD, GLW, HAS, HNP, HP, HRL, JPM, LLL, LNC, LSI, MGA, NEM, OCR, OI, PSA, RRC, STJ, SWN, TAP, TMO, TSN, XEC, NSANY, ILMN, ADBE, CELG, CHRW, GILD, MCHP, MYL, NVDA, ORLY, OTEX, PCLN, SIAL, YHOO
Read

Latest Tweets for $CVD

No tweets yet!

PARTNER HEADLINES